SURVYR

ITGR

Integer Holdings Corporation
$126.75
+$0.05 (0.04%)Oct 19 close
Health CareS&P 600 CompareTechnicals
1M3M6M1Y2Y
-42%-27%-12%+3%+18%Oct 2025Oct 2026Apr 202652w high $126.8352w low $62.00
ITGRSPY
Wall St. Highest PT $127.00 (+0.2%) Wall St. Avg PT $121.80 (-3.9%)
$63$80$97$114$131POC $88Hi $127Avg $122
Underwater Drawdown %Max DD -42.0%Current 0.0%
0.0%-42.0%
Relative Strength vs SPY+2.6% vs SPYOutperforming
+49%0%-49%
1W
+$0.23 (0.18%)
1M
+$0.47 (0.37%)
3M
+$30.66 (31.91%)
6M
+$37.43 (41.91%)
YTD
+$48.32 (61.61%)
1Y
+$21.92 (20.91%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Analyst price targets
Current price$126.75
Average target$121.80
−$4.95 (−3.9%) downsideaverage target vs current price
CurrentAverageMedian
Low$101.00
Median$121.80
High$127.00
12-month Wall Street target range
Recent analyst rating changes · 30
Downgrade
2026-08-14 · Benchmark downgraded ITGR from Buy to Hold
Downgrade
2026-08-04 · Oppenheimer downgraded ITGR from Outperform to Perform
Downgrade
2026-08-04 · Truist Securities downgraded ITGR from Buy to Hold
Reiterated
2026-08-04 · Wells Fargo reiterated Equal-Weight on ITGR
Downgrade
2026-08-04 · Freedom Capital Markets downgraded ITGR from Buy to Hold
Downgrade
2026-08-03 · Keybanc downgraded ITGR from Overweight to Sector Weight
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$4.3B
P/E (last 12 months)34.6
P/E (next 12 months, estimated)18.4
52-week range$62.00 – $126.83
Revenue growth (latest quarter vs a year ago)-2.6%
Dividend yieldNo dividend
Average analyst price target$121.80 (-4%)

What they do

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology. It also provides cardiac rhythm management products, including implantable pacemakers.

Healthcare · Medical Devices
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
96th percentile in sector
A+
12-1 return: +95.7%
Percentile within its GICS sector across the S&P 1500.
Growth
7th percentile in sector
F
Revenue growth (YoY): -2.6%
Percentile within its GICS sector across the S&P 1500.
Value
46th percentile in sector
C
Forward E/P: 5.4% · EBITDA/EV: 6.2%
Percentile within its GICS sector across the S&P 1500.
Profitability
45th percentile in sector
C
Profit margin: +7.0% · Return on equity: +7.5%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

ITGR earningsReports tomorrow
Next report · quarter Sep 2026
Thu Oct 29, 2026Before the open
EPS consensus$1.68 range $1.62–$1.76
Revenue consensus$457.2M 10 analysts
Last 4 quarters · EPS vs estimate
Aug 3, 2026$1.60est $1.38+15.8%Above estimates
Apr 30, 2026$1.20est $1.19+1.1%In line with estimates
Feb 19, 2026$1.76est $1.70+3.6%Above estimates
Oct 23, 2025$1.79est $1.68+6.8%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-24 08:49:33 ET
24-1025-0225-0425-0725-1026-0226-0426-080.001.79
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$464.1M-2.6%
2026-03-31$439.6M–
2025-12-31$472.1M–
2025-09-30$467.7M–
2025-06-30$476.5M–

News & catalysts

More news
Integer Holdings Corporation (ITGR) files 8-K: Reg FD disclosure
SEC 8-K · Oct 21
Rating changes
Downgrade
2026-08-14 · Benchmark downgraded ITGR from Buy to Hold
Downgrade
2026-08-04 · Oppenheimer downgraded ITGR from Outperform to Perform
Downgrade
2026-08-04 · Truist Securities downgraded ITGR from Buy to Hold
Reiterated
2026-08-04 · Wells Fargo reiterated Equal-Weight on ITGR
Downgrade
2026-08-04 · Freedom Capital Markets downgraded ITGR from Buy to Hold
Downgrade
2026-08-03 · Keybanc downgraded ITGR from Overweight to Sector Weight

Third-party analyst actions, not SURVYR.'s views. All rating changes

Stats refreshed 2026-10-24 08:49:33 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026